Bullish option flow detected in Bausch Health (BHC) with 5,026 calls trading, 2x expected, and implied vol increasing over 2 ...

Evercore ISI upgraded shares of Bausch Health Companies (TSE:BHC – Free Report) to a hold rating in a research note published ...

Evercore ISI upgraded shares of Bausch + Lomb (NYSE:BLCO – Free Report) from an in-line rating to an outperform rating in a ...

Bausch Health has recently changed its strategy for Bausch + Lomb, looking to sell the segment which has a market capitalization of nearly $8 billion. The potential sale of Bausch + Lomb is a break ...

The global aesthetic medical device market, valued at USD 13.73 billion in 2024, is set for steady growth over the next ...

MGP Ingredients expects a downbeat third quarter and lowered its full-year outlook, as weak demand and high inventories have hurt the company's whiskey sales. The distilled-spirits and ...

The potential sale of its 88% stake in Bausch + Lomb could generate billions for creditors and shareholders of the indebted ...

In a report released yesterday, Larry Biegelsen from Wells Fargo assigned a Buy rating on Bausch + Lomb Corporation (BLCO – Research ...

In a report released today, Umer Raffat from Evercore ISI maintained a Hold rating on Bausch Health Companies (BHC – Research Report).

We are thrilled to welcome Dr. Wechsler to our Board of Directors,” said Dr. Carl Goldfischer, Chair of the Board of Galecto. “Amy is a distinguished physician who has board certification in both ...

After kicking off a sales process roughly a month ago, eye-health firm Bausch + Lomb has stirred up significant interest from ...

Shares of contact lens supplier Bausch + Lomb ($BLCO) are surging in today’s trading amid news of a potential acquisition.